Sign In
Buy CG
$42.24
-2.25 (-5.06%)
At Close: Jun 03, 2026
Carlyle Secured Lending: NAV Continues To Slide Due To Weak Earnings
12:34am, Sunday, 01'st Jun 2025
Carlyle Secured Lending's fundamentals remain solid, but rising non-accruals and shrinking net investment income raise concerns about portfolio health and dividend sustainability. Despite a 21% price
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
08:30am, Friday, 30'th May 2025
WASHINGTON & NEW YORK--(BUSINESS WIRE)--Carlyle (NASDAQ: CG) (“Carlyle”), SK Capital Partners, LP (“SK Capital”) and Beacon Parent Holdings, L.P. (“Parent”) today announced that the tender
Carlyle Group: Recurring Revenue Makes Shares Attractive
11:45pm, Wednesday, 28'th May 2025
Carlyle Group offers value with shares 20% below highs, strong AUM growth, and a secure 3.2% dividend yield. Fee-based earnings are highly predictable, with $26B pending fee-earning AUM and credible 6
bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital
08:30am, Tuesday, 27'th May 2025
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird” or “the Company”) today reminds all stockholders to promptly tender their shares into the tender offer by Carl
Carlyle and Axcap Sign Definitive Mineral Property Agreement for Sale of Newton Gold Project
04:00am, Monday, 26'th May 2025
Axcap signs definitive Mineral Property Purchase Agreement acquiring the Newton Gold Project located in British Columbia, Canada The Newton Gold Project has an inferred mineral resource containing 842
Carlyle's Jeff Currie: OPEC supply increases have been bearish surprise for the market
11:44am, Thursday, 22'nd May 2025
Jeff Currie, Carlyle chief strategy officer of energy pathways, joins CNBC's 'Squawk on the Street' to discuss outlooks on energy.
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--StandardAero, Inc. (NYSE: SARO) (“StandardAero” or the “Company”) announced today the pricing of its underwritten public offering by two of its stockholders
Carlyle Credit Income Fund Announces Second Quarter Financial Results and Declares Monthly Common and Preferred Dividends
04:10pm, Tuesday, 20'th May 2025
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund (“we,” “us,” “our,” “CCIF” or the “Fund”) (NYSE: CCIF) today announced its financial results for its second qu
StandardAero Announces Secondary Offering of 30,000,000 Shares of Common Stock by Affiliates of The Carlyle Group Inc. and GIC
04:31pm, Monday, 19'th May 2025
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--StandardAero, Inc. (NYSE: SARO) (“StandardAero” or the “Company”) announced today that two of its stockholders (the “Selling Stockholders”), affiliates
Resonetics® Invests in Nitinol Gun Drilling Capabilities Through Purchase of Assets from Medical Component Specialists
10:00am, Monday, 19'th May 2025
Establishes nitinol input tube operation to support premium, implant-grade tubing initiative and strengthen supply chain resilience NASHUA, N.H. , May 19, 2025 /PRNewswire/ -- Resonetics® announced t
Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions
04:30pm, Friday, 16'th May 2025
SOMERVILLE, Mass.--(BUSINESS WIRE)--As previously announced on May 14, 2025, Carlyle (NASDAQ: CG) (“Carlyle”), SK Capital Partners, LP (“SK Capital”) and bluebird bio, Inc. (NASDAQ: BLUE) (“
bluebird bio shares soar after amended buyout offer from Carlyle, SK Capital
12:07pm, Wednesday, 14'th May 2025
Shares of bluebird bio Inc (NASDAQ:BLUE) surged 50% on Wednesday after the gene therapy developer announced an amended acquisition agreement with private equity firms Carlyle and SK Capital, offering
Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital
08:52am, Wednesday, 14'th May 2025
Bluebird bio and Carlyle Group and SK Capital Partners said on Wednesday that the private equity firms have offered $5 per share upfront to takeover the gene therapy maker.
Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement
08:30am, Wednesday, 14'th May 2025
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”), Carlyle (NASDAQ: CG) (“Carlyle”) and SK Capital Partners, LP (“SK Capital”) today announced they have am
Carlyle (CG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
08:31pm, Friday, 09'th May 2025
Although the revenue and EPS for Carlyle (CG) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street es
